EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans

Aihan Zhang, Gadea Meecham-Garcia, Chiminh Nguyen Hong, Peiyun Xie, Carina C Kern, Bruce Zhang, Hannah Chapman, David Gems

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2024

DOI: 10.1093/gerona/glae196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2024. Verfasst von Aihan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Healthy Ageing, and Research Department of Genetics, Evolution and Environment, University College London, London, UK. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Sirolimus, Aging, Longevity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIH HHS, ODCDC CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacological inhibition of the mechanistic target of rapamycin (mTOR) signaling pathway with rapamycin can extend lifespan in several organisms. Although this includes the nematode Caenorhabditis elegans, effects in this species are relatively weak and sometimes difficult to reproduce. Here we test effects of drug dosage and timing of delivery to establish the upper limits of its capacity to extend life, and investigate drug effects on age-related pathology and causes of mortality. Liposome-mediated rapamycin treatment throughout adulthood showed a dose-dependent effect, causing a maximal 21.9% increase in mean lifespan, but shortening of lifespan at the highest dose, suggesting drug toxicity. Rapamycin treatment of larvae delayed development, weakly reduced fertility and modestly extended lifespan. By contrast, treatment initiated later in life robustly increased lifespan, even from Day 16 (or ~70 years in human terms). The rapalog temsirolimus extended lifespan similarly to rapamycin, but effects of everolimus were weaker. As in mouse, rapamycin had mixed effects on age-related pathologies, inhibiting one (uterine tumor growth) but not several others, suggesting a segmental antigeroid effect. These findings should usefully inform future experimental studies with rapamycin and rapalogs in C. elegans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansSirolimusAgingLongevityMTOR InhibitorsAnimalsTOR Serine-Threonine KinasesDose-Response Relationship, DrugSignal Transduction

Stichwörter der Autor:innen

Age-related pathologyLifespanRapalogRapamycinmTOR

Substanzen

SirolimusMTOR InhibitorsTOR Serine-Threonine Kinasestemsirolimus

Autor:innen und Institutionen

  • Institute of Healthy Ageing, and Research Department of Genetics, Evolution and Environment, University College London, London, UK.

Förderung

  • Wellcome Trust
  • NIH HHS
  • ODCDC CDC HHS
  • NIH Office of Research Infrastructure Programs

Zitieren

APA

Zhang, A., Meecham-Garcia, G., Nguyen Hong, C., Xie, P., Kern, C. C., Zhang, B., Chapman, H., & Gems, D. (2024). Characterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glae196

Vancouver

Zhang A, Meecham-Garcia G, Nguyen Hong C, Xie P, Kern CC, Zhang B, et al. Characterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2024. doi:10.1093/gerona/glae196

BibTeX
@article{Zhang2024,
  author = {Zhang, Aihan and Meecham-Garcia, Gadea and Nguyen Hong, Chiminh and Xie, Peiyun and Kern, Carina C and Zhang, Bruce and Chapman, Hannah and Gems, David},
  title = {Characterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2024},
  doi = {10.1093/gerona/glae196}
}
Kostenlos starten →